1 Introduction to Research & Analysis Reports
1.1 Recombinant Antibody Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Recombinant Antibody Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Recombinant Antibody Overall Market Size
2.1 China Recombinant Antibody Market Size: 2021 VS 2027
2.2 China Recombinant Antibody Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Recombinant Antibody Players in China Market
3.2 Top China Recombinant Antibody Companies Ranked by Revenue
3.3 China Recombinant Antibody Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Antibody Companies in China Market, by Revenue in 2020
3.5 Companies Recombinant Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Antibody Players in China Market
3.6.1 List of Tier 1 Recombinant Antibody Companies in China
3.6.2 List of Tier 2 and Tier 3 Recombinant Antibody Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Recombinant Antibody Market Size Markets, 2021 & 2027
4.1.2 Chimeric Antibody
4.1.3 Humanized Antibody
4.1.4 Full Human Antibody
4.1.5 Single Chain Antibody
4.1.6 Bispecific Antibody
4.2 By Type - China Recombinant Antibody Revenue & Forecasts
4.2.1 By Type - China Recombinant Antibody Revenue, 2016-2021
4.2.2 By Type - China Recombinant Antibody Revenue, 2022-2027
4.2.3 By Type - China Recombinant Antibody Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Recombinant Antibody Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Scientific Research
5.1.4 Others
5.2 By Application - China Recombinant Antibody Revenue & Forecasts
5.2.1 By Application - China Recombinant Antibody Revenue, 2016-2021
5.2.2 By Application - China Recombinant Antibody Revenue, 2022-2027
5.2.3 By Application - China Recombinant Antibody Revenue Market Share, 2016-2027
6 Recombinant Antibody Companies Profiles
6.1 Abnova
6.1.1 Abnova Company Details
6.1.2 Abnova Business Overview
6.1.3 Abnova Recombinant Antibody Introduction
6.1.4 Abnova Recombinant Antibody Revenue in China Market (2016-2021)
6.1.5 Abnova Recent Developments
6.2 Medix Biochemica
6.2.1 Medix Biochemica Company Details
6.2.2 Medix Biochemica Business Overview
6.2.3 Medix Biochemica Recombinant Antibody Introduction
6.2.4 Medix Biochemica Recombinant Antibody Revenue in China Market (2016-2021)
6.2.5 Medix Biochemica Recent Developments
6.3 GE Healthcare
6.3.1 GE Healthcare Company Details
6.3.2 GE Healthcare Business Overview
6.3.3 GE Healthcare Recombinant Antibody Introduction
6.3.4 GE Healthcare Recombinant Antibody Revenue in China Market (2016-2021)
6.3.5 GE Healthcare Recent Developments
6.4 SinoBiological
6.4.1 SinoBiological Company Details
6.4.2 SinoBiological Business Overview
2021-2027中國重組抗體產(chǎn)業(yè)分析和趨勢預(yù)測報告
6.4.3 SinoBiological Recombinant Antibody Introduction
6.4.4 SinoBiological Recombinant Antibody Revenue in China Market (2016-2021)
6.4.5 SinoBiological Recent Developments
6.5 Bioventix
6.5.1 Bioventix Company Details
6.5.2 Bioventix Business Overview
6.5.3 Bioventix Recombinant Antibody Introduction
6.5.4 Bioventix Recombinant Antibody Revenue in China Market (2016-2021)
6.5.5 Bioventix Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Recombinant Antibody Market Opportunities & Trends in China Market
Table 2. Recombinant Antibody Market Drivers in China Market
Table 3. Recombinant Antibody Market Restraints in China Market
Table 4. Key Players of Recombinant Antibody in China Market
Table 5. Top Recombinant Antibody Players in China Market, Ranking by Revenue (2019)
Table 6. China Recombinant Antibody Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Recombinant Antibody Revenue Share by Companies, 2016-2021
Table 8. Companies Recombinant Antibody Product Type
Table 9. List of Tier 1 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Recombinant Antibody Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – China Recombinant Antibody Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Recombinant Antibody Revenue (US$, Mn), 2016-2021
2021-2027 zhōngguó chóngzǔ kàngtǐ chǎnyè fēnxī hé qūshì yùcè bàogào
Table 13. By Type - China Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 14. By Application – China Recombinant Antibody Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Recombinant Antibody Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Recombinant Antibody Revenue (US$, Mn), 2022-2027
Table 17. Abnova Company Details
Table 18. Abnova Business Overview
Table 19. Abnova Recombinant Antibody Product
Table 20. Abnova Recombinant Antibody Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Abnova Recent Developments
Table 22. Medix Biochemica Company Details
Table 23. Medix Biochemica Business Overview
Table 24. Medix Biochemica Recombinant Antibody Product
Table 25. Medix Biochemica Recombinant Antibody Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Medix Biochemica Recent Developments
Table 27. GE Healthcare Company Details
Table 28. GE Healthcare Business Overview
Table 29. GE Healthcare Recombinant Antibody Product
Table 30. GE Healthcare Recombinant Antibody Revenue in China Market (2016-2021) & (US$ Million)
Table 31. GE Healthcare Recent Developments
Table 32. SinoBiological Company Details
Table 33. SinoBiological Business Overview
Table 34. SinoBiological Recombinant Antibody Product
Table 35. SinoBiological Recombinant Antibody Revenue in China Market (2016-2021) & (US$ Million)
Table 36. SinoBiological Recent Developments
Table 37. Bioventix Company Details
Table 38. Bioventix Business Overview
Table 39. Bioventix Recombinant Antibody Product
Table 40. Bioventix Recombinant Antibody Revenue in China Market (2016-2021) & (US$ Million)
2021-2027中國組換え抗體産業(yè)分析と傾向予測レポート
Table 41. Bioventix Recent Developments
List of Figures
Figure 1. Recombinant Antibody Segment by Type
Figure 2. Recombinant Antibody Segment by Application
Figure 3. China Recombinant Antibody Market Overview: 2020
Figure 4. China Recombinant Antibody Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Recombinant Antibody Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Recombinant Antibody Revenue in 2020
Figure 7. By Type - China Recombinant Antibody Revenue Market Share, 2016-2027
Figure 8. By Application - China Recombinant Antibody Revenue Market Share, 2016-2027
Figure 9. Abnova Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Medix Biochemica Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. GE Healthcare Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. SinoBiological Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Bioventix Recombinant Antibody Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
……
如需訂購《2021-2027 China Recombinant Antibody Industry Analysis and Trends Forecast Report》，編號：3152927
請您致電：400 612 8668、010-6618 1099、66182099、66183099
Email：KF@Cir.cn 【網(wǎng)上訂購】 ｜ 下載《訂購協(xié)議》 ｜ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
Email：KF@Cir.cn 【網(wǎng)上訂購】 ｜ 下載《訂購協(xié)議》 ｜ 了解“訂購流程”
京公網(wǎng)安備 11010802027365號